Ultragenyx Pharma (RARE) call put ratio 1 call to 3 puts into Phase 3 results
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Join SI Premium – FREE
Ultragenyx Pharma (NASDAQ: RARE) 30-day option implied volatility is at 170; compared to its 52-week range of 40 to 182. Call put ratio 1 call to 3 puts into Phase 3 results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Shake Shack (SHAK) at Outperform
- RBC Capital Downgrades AGF Management Ltd. (AGF/B:CN) (AGFMF) to Sector Perform
- RBC Capital Downgrades Biohaven Pharma (BHVN) to Sector Perform
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
